+ Add To DealsPlus

Forbes

News
Nov 23, 2020
2  Likes 0  Comments

About this Deal

Pharmaceutical giant AstraZeneca is preparing to submit its Covid-19 vaccine, developed in conjunction with the University of Oxford, to regulatory authorities for emergency approval after a preliminary analysis of an ongoing clinical trial revealed it to be up to 90% effective at preventing Covid-19. — while the findings follow 95% success rates from Moderna and Pfizer’s vaccines, the Oxford vaccine is cheaper and much easier to store and transport.
What's the matter?

💬 Comments

Thanks! Worked! 👍 🙏 🤩 💕 🥳 🔥 😍
👀 Related Deals